Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracervical terlipressin for reducing gas embolism and fluid intravasation during hysteroscopic surgery
NL-OMON41343Recruiting
- Sponsor
- OLVG
- Start
- Aug 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Trial of terlipressin in Fibromyoma (LM) and hypermenorrhea (2 arms), sponsored by OLVG. Primary endpoint: Incidence and severity of gas embolism. Started Aug 2013; status: recruiting.
02
Drugs
terlipressin
03
Conditions
Fibromyoma (LM)hypermenorrhea
Beyond the preview
Go deeper on NL-OMON41343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41343.